Risk of Bladder Cancer in Those Who Take Actos for Type-2 Diabetes
Actos is a drug prescribed for treatment of people with Type-2 diabetes, and works to maintain proper levels of sugar. Actos is usually prescribed in combination with changes in dietary habits. The drug comes with a series of health warnings that mainly address the possibility of heart failure and lactic acidosis. However, Actos has recently come under investigation from a variety of sources as a possible cause of bladder cancer.
In June 2011, Takeda Pharmaceuticals halted sales of Actos in France and Germany, following a nationwide recall and banning of the medication. Since then, based on a study from the Food and Drug Administration (FDA), the FDA has issued warnings about the risk of bladder cancer in people who take Actos. Further, doctors are now being advised not to prescribe this medication for those afflicted with Type-2 diabetes.
In the last month, the first of what lawyers predict will be thousands of lawsuits were filed in courts across the country against Takeda Pharmaceuticals. The lawsuits allege that Actos triggered bladder cancer in people who took the drug daily for years. If you or a loved one has been taking Actos for an extended period, you may want to follow-up with your health care providers and inquire as to this serious side-effect.
